category supply-chain-logistics 
Pharmaceutical Technology
DECEMBER 19, 2022
Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. The Environmental category aims to highlight companies that are undertaking projects that reduce their impact on the natural environment or contribute to its general health. Business Expansion. Environmental.
Pharmaceutical Technology
DECEMBER 22, 2022
Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. The Environmental category aims to highlight companies that are undertaking projects that reduce their impact on the natural environment or contribute to its general health. Business Expansion. Innovation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ACRP blog
SEPTEMBER 27, 2023
As specialty drugs continue to be the main category in the FDA’s pipeline for new approvals as of mid-2023, and it has been projected that 13 new cell or gene therapies could be approved in the U.S., Europe, or both by the end of 2023, optimizing the supply chain must a priority throughout the pre-commercialization phase of drug development.”
XTalks
APRIL 2, 2024
The report also found that 70 percent of healthcare emissions come from the pharmaceutical supply chain. A company’s ESG risk rating is comprised of a quantitative score and a risk category. It is also looking to reduce emissions, from a 2019 baseline, for upstream logistics by ten percent and business travel by 25 percent.
Pharmaceutical Technology
MAY 24, 2023
Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. CGT drugs fall into two major categories: autologous and allogeneic. Differences in CGT vs traditional trials supply chain.
FDA Law Blog
OCTOBER 12, 2022
Because naloxone is a prescription drug, its distribution is subject to the requirements of the Drug Supply Chain Security Act (DSCSA). It may not be clear to supply chain stakeholders which entities may be considered “harm reduction programs” for the purposes of this Guidance.
XTalks
FEBRUARY 8, 2021
While some beverage brands have a more focused approach with a core product category, other typically larger and more established brands have a large portfolio of beverage products. It is typically divided into two subcategories, alcoholic and non-alcoholic, with many brands venturing into both segments to appeal to a wider consumer base.
Expert insights. Personalized for you.
130 
Let's personalize your content